| |
|
|
|
Oncosec Medical  
|
|
2 -0.21 (-0.1%) |
09-16 16:00 |
|
Open: |
2.18 |
Pre close: |
2.21 |
Target:
|
2.57 
|
|
High: |
2.18 |
Low: |
1.9829 |
Resistance:
|
2.20
2.42
|
|
Volume: |
190,809 |
Market Cap: |
78M |
Support:
|
1.84
1.53
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.07
|
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
2.15 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
3.03 |
Stochastic Oscillator |
%K(14,3):
|
24.11 |
|
MA(250): |
4.42 |
%D(3): |
28.66 |
|
Average Volume(K) |
3-Month: |
1135729
|
52-Week |
High:
|
8.16 |
|
10-Days: |
209032 |
Low: |
1.84 |
|
RSI |
RSI(14):
|
41.77 |
Change(%): |
-55.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.708 |
Return on Equity (ttm) |
-166.8 |
Shares Out. (M) |
37.15 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-61.4 |
Shares Float (M) |
13.21 |
|
EPS Est. Next Year |
-0.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
37.28 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
11.47 |
|
Forward EPS |
-4.290 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
477 |
|
Book Value (p.s.) |
1.320 |
EBITDA (p.s.) |
-1.181 |
P/E |
-1.17 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.52 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-38.16 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-22.10 |
P/CF |
-1.95 |
|
|
|
|
|
|
